Illinois Scientist Developing Cancer Drug Delivery Method with Bioengineered Microbes

Shannon Sirk and the Sirk Research Group

A team led by Shannon Sirk is developing a new method of producing and delivering monoclonal antibody treatments for breast cancer using bioengineered microbes—work that could improve access to the treatment and dramatically reduce costs.

Link to Full Story

Cancer Center at Illinois

Apr 03, 2022

Around Campus